Sandoval ML, Latifi K, Parsee A, Andreozzi J, et al. Defining MR-Based Parameters of Treatment Response to Immune-Modulatory Therapy for Grade Group 5 Prostate Cancer. Int J Radiat Oncol Biol Phys 2021;111.
PMID: 34701110